Literature DB >> 12674754

Effect of HDL and apoAI on PGE2 production by monocyte-derived macrophages.

Xiaoqin Zhou1, Arnold von Eckardstein.   

Abstract

Effect of antiatherogenic high density lipoprotein (HDL) and apolipoprotein AI (apoAI) on production of prostaglandin E2 (PGE2) by human monocyte-derived macrophages was investigated. Macrophages were loaded with acetylated low density lipoprotein followed by incubation with HDL3 or apoAI. PGE2 produced and secreted in culture supernatant was quantified by enzyme immunoassay. HDL3 induced production of PGE2 by macrophages in a time-dependent manner. 24 h after incubation, PGE2 production by HDL3-treated macrophages increased 3.7-fold of that by control cells. ApoAI also induced PGE2 secretion to 2.1-fold, which was significantly less than HDL3. The data indicate that both HDL3 and lipid-free apoAI enhance PGE2 synthesis and secretion by human macrophages and this may further contribute to the protection from atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12674754     DOI: 10.1007/BF02896760

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  12 in total

1.  Westernization of Chinese adults and increased subclinical atherosclerosis.

Authors:  K S Woo; P Chook; O T Raitakari; B McQuillan; J Z Feng; D S Celermajer
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-10       Impact factor: 8.311

2.  Dysregulation of lipid metabolism in Tangier monocyte-derived macrophages.

Authors:  G Schmitz; H Fischer; M Beuck; K P Hoecker; H Robenek
Journal:  Arteriosclerosis       Date:  1990 Nov-Dec

3.  Monocyte prostaglandins inhibit procollagen secretion by human vascular smooth muscle cells: implications for plaque stability.

Authors:  C Fitzsimmons; D Proudfoot; D E Bowyer
Journal:  Atherosclerosis       Date:  1999-02       Impact factor: 5.162

Review 4.  Signal transduction in atherosclerosis: integration of cytokines and the eicosanoid network.

Authors:  D P Hajjar; K B Pomerantz
Journal:  FASEB J       Date:  1992-08       Impact factor: 5.191

5.  Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.

Authors:  S K Basu; J L Goldstein; G W Anderson; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

6.  Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

Authors:  G J Miller; N E Miller
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

7.  Prostaglandin E2 biosynthesis and effect in pigeon aorta. Possible role in atherogenesis.

Authors:  M T Subbiah
Journal:  Atherosclerosis       Date:  1978-04       Impact factor: 5.162

Review 8.  Coronary heart disease: reducing the risk: the scientific background to primary and secondary prevention of coronary heart disease. A worldwide view. International Task force for the Prevention of Coronary Heart disease.

Authors:  G Assmann; P Cullen; F Jossa; B Lewis; M Mancini
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-08       Impact factor: 8.311

9.  Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins.

Authors:  L N Fleisher; A R Tall; L D Witte; R W Miller; P J Cannon
Journal:  J Biol Chem       Date:  1982-06-25       Impact factor: 5.157

10.  Inhibitory effect of prostaglandin E2 on cholesterol ester accumulation in macrophages.

Authors:  N Morisaki; T Kanzaki; M Kitahara; Y Saito; S Yoshida
Journal:  Biochem Biophys Res Commun       Date:  1986-05-29       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.